CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Amicogen Inc Company Snapshot
Amicogen Inc operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Amicogen Inc with three other companies in this sector in KOREA (SOUTH) : Hwail Pharmaceutical Company Limited (2019 sales of 108.74 billion Korean Won [US$88.63 million] ), Ctc Bio, Incorporation. (136.12 billion Korean Won [US$110.94 million] of which 80% was Animal Medication), and Samil Pharmaceutical Co., Ltd. (121.11 billion Korean Won [US$98.70 million] ).

Sales Analysis. Amicogen Inc reported sales of 115.18 billion Korean Won (US$93.87 million) for the year ending December of 2019. This represents an increase of 21.9% versus 2018, when the company's sales were 94.52 billion Korean Won . Sales at Amicogen Inc have increased during each of the previous five years (and since 2014, sales have increased a total of 321%). Sales of Health Functional Food saw an increase that was more than double the company's growth rate: sales were up 60.6% in 2019, from 17.37 billion Korean Won to 27.89 billion Korean Won . Amicogen Inc also saw significant increases in sales in Cefdinir (up 44.7% to 7.55 billion Korean Won ) and Enzyme (up 30.1% to 7.18 billion Korean Won ) . Not all segments of Amicogen Inc experienced an increase in sales in 2019: sales of Ceftiofur fell 32.5% to 9.42 billion Korean Won .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Amicogen Inc
  Stock Performance Chart for Amicogen Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (5/22/2020): 30,650
(Figures in Korean Won )
1 Week 4.1%   13 Weeks 4.3%  
4 Weeks 29.9%   52 Weeks 14.4%  
 
Amicogen Inc Key Data:
  Ticker: 092040 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2019 Sales 115,180,889,376
(Year Ending Jan 2020).
Employees: 113
  Currency: Korean Won Market Cap: 582,499,602,650
  Fiscal Yr Ends: December Shares Outstanding: 19,004,881
  Share Type: Ordniary Closely Held Shares: 4,106,018
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.